Event Brief
Dec 11, 2025 at 7:01 AM ET
Eli Lilly's obesity drug shows strong results in trials
By The BriefBrief
Retatrutide demonstrates significant weight loss and knee pain reduction in late-stage trials, enhancing Eli Lilly's obesity portfolio.
WHO: Eli Lilly
WHAT: Next-generation obesity drug trial results
WHEN: Dec 10, 2025 at 7:00 PM ET
WHERE: Not specified
WHY: To expand obesity treatment options and improve patient outcomes
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Final defendant sentenced in Zaria McKeever murder case
Zaria Mckeever
May 1, 2026 at 3:23 PM ET
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21416 of 21416
Same format. Every time.
Continue reading — sign in or create a free account with
